Fidelity Advisor® Biotechnology Fund

Scorecard
3 / 5 Stars
Lipper
5 4 3 2 4
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
5 / 5 Stars
TheStreet.com
A (Buy)

Fund Holdings

Asset Allocation

% Long % Net
Cash 1.37 1.37
Stocks 96.63 96.63
Bonds 0.0 0.0
Other 0.0 0.0
Foreign Bonds 0.0 0.0
Foreign Stocks 1.79 1.79
Convertible 0.0 0.0
Preferred 0.22 0.22

Updated 02.28.2014

Top 10 Holdings

Performance as of 03.31.2014

Portfolio as of 02.28.2014

Ticker YTD Return % % Net Assets
Gilead Sciences Inc GILD -1.94 13.7
Amgen Inc AMGN 11.04 9.87
Biogen Idec Inc BIIB 10.81 6.55
Celgene Corporation CELG -13.24 5.3
Alexion Pharmaceuticals, Inc. ALXN 16.9 4.7
Intercept Pharmaceuticals Inc ICPT 389.44 4.09
Regeneron Pharmaceuticals, Inc. REGN 11.5 3.65
Vertex Pharmaceuticals Inc VRTX -3.27 3.04
Biomarin Pharmaceutical, Inc. BMRN -2.47 2.39
Incyte Corp Ltd INCY 8.16 1.7

See Also:

Top Fidelity Investments Funds